Is Xeroderma Pigmentosum hereditary?

Xeroderma Pigmentosum is an inherited genetic condition caused by mutations in genes involved in DNA repair, meaning it is passed from parents to their children through the germline.

Understanding the Inheritance Pattern

While the condition is genetic, it is specifically inherited in an autosomal recessive pattern. This means that for a child to be born with Xeroderma Pigmentosum, they must inherit two copies of the mutated gene—one from each biological parent. Parents of an affected individual are typically "carriers," meaning they possess one mutated gene and one functional gene; they generally do not show symptoms of Xeroderma Pigmentosum themselves. Because the inheritance is recessive, there is a 25% chance for each pregnancy between two carrier parents to result in an affected child.

Genetic Testing and Counseling

Genetic testing for Xeroderma Pigmentosum is highly recommended to confirm a clinical diagnosis, as it helps identify which of the complementation groups (XPA through XPG or the variant form) is involved. Testing is performed through molecular genetic analysis, such as gene panels or whole-exome sequencing. If you are planning a pregnancy and have a family history of the condition, genetic counseling is essential to discuss carrier testing for partners and reproductive options, such as preimplantation genetic testing (PGT) or prenatal diagnosis via amniocentesis or chorionic villus sampling.

De Novo Mutations and Frequency

Spontaneous or de novo mutations—those that occur for the first time in an individual and are not inherited from parents—are extremely rare in Xeroderma Pigmentosum. The vast majority of cases arise from the inheritance of recessive alleles from carrier parents. Because Xeroderma Pigmentosum involves complex DNA repair pathways, understanding your specific genetic profile is a critical step in managing long-term care and informing family planning decisions.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• OMIM (Online Mendelian Inheritance in Man)


• Xeroderma Pigmentosum Society (XPS)